Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Cancer|July 13, 2021
Outcomes of TP53-mutant acute myeloid leukemia with decitabine and venetoclaxKunhwa Kim, Abhishek Maiti, Sanam Loghavi, et al.
Journal of Pediatric Urology|March 28, 2022
Surgical experiences in adolescents and young adults with differences of sex development: A qualitative examinationKassie D Flewelling, Stephanie De Jesus Ayala, Yee-Ming Chan, et al.
Haematologica|March 23, 2023
Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)Guillaume Richard-Carpentier, Caitlin R Rausch, Koji Sasaki, et al.
Cell Reports|November 13, 2024
Karyotype evolution in response to chemoradiotherapy and upon recurrence of esophageal adenocarcinomasKaren van der Sluis, Johanna W van Sandick, Willem J Koemans, et al.
The Lancet. Haematology|March 7, 2024
Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 studyAlexandre Bazinet, Guillermo Garcia-Manero, Nicholas Short, et al.
American Journal of Hematology|August 28, 2023
Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemiaTapan M Kadia, Farhad Ravandi, Matteo Molica, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2020
Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 StudyPrithviraj Bose, David McCue, Sebastian Wurster, et al.
Cancer|August 3, 2021
Ten-day decitabine with venetoclax versus intensive chemotherapy in relapsed or refractory acute myeloid leukemia: A propensity score-matched analysisAbhishek Maiti, Courtney D DiNardo, Wei Qiao, et al.
Cancer|April 1, 2021
Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemiaCaitlin R Rausch, Courtney D DiNardo, Abhishek Maiti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2022
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid LeukemiaTapan M Kadia, Patrick K Reville, Xuemei Wang, et al.
Pageof 15